검색어 : 통합검색[Symons Julian]
총 116건 중 116건 출력
, 11/12 페이지
-
101
- Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses
- Gueulette, John; Bö hm, Lothar; Slabbert, Jacobus P; De Coster, Blanche M; Rutherfoord, Gerald S; Ruifrok, Arnout; Octave-Prignot, Michelle; Binns, Peter J; Schreuder, A.Nicholaas; Symons, Julian E; Scalliet, Pierre; Jones, Dan T.L; ; (International journal of radiation oncology, biology, physics, v.47, 2000, pp.1051-1058)
-
102
- TOP-358-YI Non-HAP CAM-A ALG-006746 and ALG-006780 induce rapid HBsAg reductions in AAV-HBV mice and have favorable pharmacokinetic profiles
- Vanrusselt, Hannah; Verheyen, Jordi; Gupta, Kusum; Degrauwe, Lars; Liu, Cheng; Sanchez, Abel Acosta; Bollier, Mé lanie; Nshimyumuremyi, Jean-Boris; Verburgh, Benjamin; Peter, Clovis; Zhang, Qingling; Blatt, Lawrence; Beigelman, Leonid; Symons, Julian; Chanda, Sushmita; Smith, David; Jekle, Andreas; Vendeville, Sandrine; McGowan, David; Debing, Yannick; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.80, 2024, pp.S728)
-
103
- Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models
- Jekle, Andreas; Thatikonda, Santosh Kumar; Jaisinghani, Ruchika; Ren, Suping; Kinkade, April; Stevens, Sarah K.; Stoycheva, Antitsa; Rajwanshi, Vivek K.; Williams, Caroline; Deval, Jerome; Mukherjee, Sucheta; Zhang, Qingling; Chanda, Sushmita; Smith, David B.; Blatt, Lawrence M.; Symons, Julian A.; Gonzalvez, Francois; Beigelman, Leonid; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., South San Fra; (International journal of molecular sciences, v.24, 2023, pp.16274)
-
104
- THU-198 In vitro and in vivo pharmacological characterization of human PNPLA3-targeting short interfering RNA molecules for the treatment of metabolic dysfunction-associated steatohepatitis
- Song, Jieun; Deval, Jerome; Adame, Lillian; Jaisinghani, Ruchika; Tso, Emily; Lin, Daniel; Bhattacharya, Aneerban; Stoycheva, Antitsa; Sousa, Jacquelyn; Parish, Craig; Montero, Saul Martinez; Rajwanshi, Vivek; Daguison, Shane; Gohil, Vikrant; Zhang, Qingling; Williamson, Toni; Chanda, Sushmita; Talukdar, Saswata; Smith, David; Beigelman, Leonid; Symons, Julian; Zhou, Yingjiang; Luong, Xuan; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.80, 2024, pp.S564-S565)
-
105
- FRI-257 Next generation hepatitis B virus antisense oligonucleotides incorporating novel chemistries demonstrated significantly improved properties compared to current clinical candidates
- Hong, Jin; Rajwanshi, Vivek; Lu, Jimmy; Luo, Min; Kang, Hyunsoon; Passow, Kellan; Sousa, Jacquelyn; Cho, Dana; Cortez, John; Song, Jieun; Adame, Lillian; Liu, Cheng; Stevens, Sarah; Misner, Dinah; Daguison, Shane; Gupta, Kusum; Bhattacharya, Aneerban; Stoycheva, Antitsa; Ahmed-Belkacem, Rostom; Luong, Xuan; Blatt, Lawrence; Sun, Li; Smith, David; Symons, Julian; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.82, 2025, pp.S763)
-
106
- An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients
- Debing, Yannick; Vanrusselt, Hannah; Degrauwe, Lars; de Oliveira, Daniel Apolô nio Silva; Kariuki, Christopher; Ebwanga, Ebanja Joseph; Bashir, Shahbaz; Merckx, Wouter; Thatikonda, Santhosh; Gohil, Vikrant; Smith, David; Raboisson, Pierre; Montero, Saul; Hong, Jin; Sanchez, Abel Acosta; Blatt, Lawrence; Symons, Julian; Lin, Tse-I; Beigelman, Leonid; Paeshuyse, Jan; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.78, 2023, pp.S1051)
-
107
- Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)
- Luong Xuan G.; Stevens Sarah K.; Jekle Andreas; Lin Tse-I; Gupta Kusum; Misner Dinah; Chanda Sushmita; Mukherjee Sucheta; Williams Caroline; Stoycheva Antitsa; Blatt Lawrence M.; Beigelman Leonid N.; Symons Julian A.; Raboisson Pierre; McGowan David; Vandyck Koen; Deval Jerome; ; (, v., 2020, )
-
108
- The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture
- Klumpp, Klaus; Lé vê que, Vincent; Le Pogam, Sophie; Ma, Han; Jiang, Wen-Rong; Kang, Hyunsoon; Granycome, Caroline; Singer, Margaret; Laxton, Carl; Hang, Julie Qi; Sarma, Keshab; Smith, David B.; Heindl, Dieter; Hobbs, Chris J.; Merrett, John H.; Symons, Julian; Cammack, Nick; Martin, Joseph A.; Devos, Rene; Ná jera, Isabel; ; (The Journal of biological chemistry, v.281, 2006, pp.3793-3799)
-
109
- Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
- Vandyck, Koen; McGowan, David C.; Luong, Xuan G.; Stevens, Sarah K.; Jekle, Andreas; Gupta, Kusum; Misner, Dinah L.; Chanda, Sushmita; Serebryany, Vladimir; Welch, Michael; Hu, Haiyang; Lv, Zhidan; Williams, Caroline; Maskos, Klaus; Lammens, Alfred; Stoycheva, Antitsa D.; Lin, Tse-I; Blatt, Lawrence M.; Beigelman, Leonid N.; Symons, Julian A.; Raboisson, Pierre; Deval, Jerome; Aligos Belgium BV , Gaston Geenslaan 1 , 3001 Leuven , Belgium; Aligos Therapeutics, Incorporated , 1 Corporate Drive , South San Francisco , California 94080 , United States; Aligos Therapeutics, Incorporated , 1 Corporate Drive , South San Francisco , California 94080 , United States; Aligos Therapeutics, Incorporated , 1 Corporate Drive , South San Francisco , California 94080 , United States; Aligos Therapeutics, Incorporated , 1 Corporate Drive , South San Francisco , California 94080 , United States; Aligos Therapeutics, Incorporated , 1 Corporate Drive , South San Francisco , California 94080 , United States; Aligos Therapeutics, Incorporated , 1 Corporate Drive , South San Francisco , California 94080 , United States; Aligos Therapeutics, Inco; (Journal of medicinal chemistry, v.67, 2024, pp.14840-14851)
-
110
- ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
-
Vandyck, Koen;
Abdelnabi, Rana;
Gupta, Kusum;
Jochmans, Dirk;
Jekle, Andreas;
Deval, Jerome;
Misner, Dinah;
Bardiot, Dorothé
e;
Foo, Caroline S.;
Liu, Cheng;
Ren, Suping;
Beigelman, Leonid;
Blatt, Lawrence M.;
Boland, Sandro;
Vangeel, Laura;
Dejonghe, Steven;
Chaltin, Patrick;
Marchand, Arnaud;
Serebryany, Vladimir;
Stoycheva, Antitsa;
Chanda, Sushmita;
Symons, Julian A.;
Raboisson, Pierre;
Neyts, Johan;
Aligos Belgium BV;
Rega Institute for Medical Research, KU Leuven;
Aligos Therapeutics, Inc.;
Rega Institute for Medical Research, KU Leuven;
Aligos Therapeutics, Inc.;
Aligos Therapeutics, Inc.;
Aligos Therapeutics, Inc.;
CISTIM Leuven vzw;
Rega Institute for Medical Research, KU Leuven;
Aligos Therapeutics, Inc.;
Aligos Therapeutics, Inc.;
Aligos Belgium BV;
Aligos Belgium BV;
CISTIM Leuven vzw;
Rega Institute for Medical Research, KU Leuven;
Rega Institute for Medical Research, KU Leuven;
Centre for Drug Design and Discovery (CD3), KU Leuven
Belgium
QUICK MENU
